Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Polyfunctional CD4 + T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy

Zhi-Chun Ding, Lei Huang, Bruce R. Blazar, Hideo Yagita, Andrew L. Mellor, David H. Munn, Gang Zhou

Blood (2012) 120 (11): 2229–2239.

https://doi.org/10.1182/blood-2011-12-398321

Published: 2012

Includes: Supplemental data

Journal Articles

Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites

Aurelien Marabelle, M.D., MSc, Holbrook E Kohrt, MD, Joshua Brody, MD, James Anthony Torchia, Gang Zhou, Richard Luong, BVSc, DACVP, Ranjani Rajapaksa, PhD, Victor Tse, M.D., PhD, Ronald Levy, MD

Blood (2011) 118 (21): LBA-2.

https://doi.org/10.1182/blood.V118.21.LBA-2.LBA-2

Published: 2011

Journal Articles

Chemotherapy rescues tumor-driven aberrant CD4 + T-cell differentiation and restores an activated polyfunctional helper phenotype

Zhi-Chun Ding, Bruce R. Blazar, Andrew L. Mellor, David H. Munn, Gang Zhou

Blood (2010) 115 (12): 2397–2406.

https://doi.org/10.1182/blood-2009-11-253336

Published: 2010

Includes: Supplemental data

Journal Articles

Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation

Paria Mirmonsef, Gladys Tan, Gang Zhou, Tricia Morino, Kimberly Noonan, Ivan Borrello, Hyam I. Levitsky

Blood (2008) 111 (4): 2112–2121.

https://doi.org/10.1182/blood-2007-06-096586

Published: 2008

Journal Articles

Escape from Suppression: Tumor-Specific Effector Cells Out-Compete Regulatory T Cells Following Stem Cell Transplantation.

Paria Mirmonsef, MS, Gladys Tan, Ph.D., Gang Zhou, Ph.D., Tricia Pyhel, D.O., Ivan M. Borrello, M.D., Hyam Levitsky, M.D.

Blood (2006) 108 (11): 69.

https://doi.org/10.1182/blood.V108.11.69.69

Published: 2006

Journal Articles

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

Gang Zhou, Charles G. Drake, Hyam I. Levitsky

Blood (2006) 107 (2): 628–636.

https://doi.org/10.1182/blood-2005-07-2737

Published: 2006

NARROW

Polyfunctional CD4 + T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy

Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites

Chemotherapy rescues tumor-driven aberrant CD4 + T-cell differentiation and restores an activated polyfunctional helper phenotype

Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation

Escape from Suppression: Tumor-Specific Effector Cells Out-Compete Regulatory T Cells Following Stem Cell Transplantation.

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

Email alerts

ASH Publications

American Society of Hematology

Polyfunctional CD4 + T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy

Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites

Chemotherapy rescues tumor-driven aberrant CD4 + T-cell differentiation and restores an activated polyfunctional helper phenotype

Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation

Escape from Suppression: Tumor-Specific Effector Cells Out-Compete Regulatory T Cells Following Stem Cell Transplantation.

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only